SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 413 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $11,000 | -47.6% | 113 | -31.5% | 0.00% | -33.3% |
| Q4 2019 | $21,000 | +75.0% | 165 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $12,000 | -52.0% | 165 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $25,000 | +25.0% | 165 | 0.0% | 0.00% | +33.3% |
| Q1 2019 | $20,000 | -9.1% | 165 | -17.5% | 0.00% | -25.0% |
| Q4 2018 | $22,000 | -31.2% | 200 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $32,000 | -83.3% | 200 | -86.2% | 0.01% | -84.2% |
| Q2 2018 | $192,000 | +1180.0% | 1,450 | +625.0% | 0.04% | +1166.7% |
| Q1 2018 | $15,000 | +36.4% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $11,000 | +22.2% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $9,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |